| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Xynos Konstantinos is a Chief Medical Officer at Replimune Group, Inc.. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $679K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,248 | $9.10 | $65,956.80 | -4.9% | -17.2% | - | |
| May 20, 2025 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,952 | $8.06 | $64,093.12 | -5.1% | -42.0% | - | |
| Nov 18, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,246 | $10.78 | $78,111.88 | -6.2% | +30.3% | -18.8% | |
| Jun 7, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 15,881 | $7.50 | $119,107.50 | -11.9% | +35.7% | +31.4% | |
| May 16, 2024 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 6,367 | $6.47 | $41,194.49 | -4.6% | +46.7% | +16.8% | |
| Nov 16, 2023 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 7,313 | $10.92 | $79,857.96 | -6.1% | -33.4% | +4.7% | |
| May 16, 2023 | REPL Replimune Group, Inc. | Chief Medical Officer | Sell | 771 | $18.05 | $13,916.55 | -0.6% | +6.5% | -63.2% |